北京招聘

§ 1.Registration for API and FDF including import product and local produced product ; ensuring legitimacy of promotional materials of company

§ 2.To manage registration activities of the Regulatory Affairs Department to ensure efficient compliance with the requisites of the local pharmaceutical regulatory environment

§ 3.Coordinate with global RCC/LCM/DRC/MRC/SDC to implement the new registration, variations and CEs.

§ 4.To collect compile the cases, global resources and the policies to make internal adjustment on strategy and statistics of RA Activity by training, collaboration and knowledge management.

Education: University degree in the life sciences ,Scientific academic degree, preferably in pharmacy、medicine、bio-sciences

Languages: Good command of local and English language

Experience: At least 5 years’ experience to board multifunctional experience in pharmaceutical development process and science, specifically in regulatory, clinical or chemistry. Past 3 years people management experience will be considered.

山德士是瑞士诺华集团的子公司，诺华集团是世界第三大制药公司、世界500强企业，是全球唯一在专利药、非专利药、疫苗和非处方药业务上都拥有领导地位的制药公司。诺华集团成立于1996年，由瑞士两家具有百年历史的世界著名制药公司汽巴-嘉基与山德士合并而成。山德士主要从事非专利药品的研发、生产和销售，业务涵盖原料药、制剂和生物制品，拥有950多个化合物和5000多种制剂，是全球第二大非专利药公司。山德士（中国）2007年1月正式开展中国业务，于当年12月20日向德国格兰泰公司收购了位于中山市火炬区健康基地的中山格兰泰制药，并在中山成立了山德士(中国)制药有限公司，注册资金2200万美元，投资总额达3500万美元.